Affordable Access

A pilot randomized controlled trial of renal protection with pioglitazone in diabetic nephropathy.

Authors
Type
Published Article
Journal
Kidney international
Publication Date
Volume
68
Issue
1
Pages
285–292
Identifiers
PMID: 15954919
Source
Medline
License
Unknown

Abstract

In patients with advanced diabetic nephropathy, we found no reduction in proteinuria over 4 months. These data are useful to design larger studies with longer duration of follow-up to demonstrate renal protection of PPAR-gamma agonists.

Statistics

Seen <100 times